A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1366
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PROs
Long Form : patient-reported outcomes
No. Year Title Co-occurring Abbreviation
2019 "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. RA
2019 A beta-binomial mixed-effects model approach for analysing longitudinal discrete and bounded outcomes. ---
2019 A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis. EQ-5D, MIS, MIS TLIF, NASS, NRS, ODI, QOD, TLIF
2019 A narrative review of data collection and analysis guidelines for comparative effectiveness research in chronic pain using patient-reported outcomes and electronic health records. CER, EHRs
2019 A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease. CD, IBD, PROBE, PROBE, QOL, UC
2019 A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes: Introduction to the Supplement. ---
2019 A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. FSMPG, Gla-300
2019 A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. BMs, BTAs, QOL, SREs
2019 A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016). EMA, FDA
10  2019 A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice. CDS
11  2019 A Systematic Review of Patient-Reported Outcomes for Cosmetic Indications of Botulinum Toxin Treatment. BTX, QOL
12  2019 Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology. IT, TEP
13  2019 Adverse Childhood Experiences Are Not Associated With Patient-reported Outcome Measures in Patients With Musculoskeletal Illness. ACEs, CI, OR, SE
14  2019 AMCP Partnership Forum: Building the Foundation for Patient-Reported Outcomes-Infrastructure and Methodologies. AMCP
15  2019 An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. FACT-B, HRQoL
16  2019 Anterior Cruciate Ligament Reconstruction With Hamstring Autograft: A Matched Cohort Comparison of the All-Inside and Complete Tibial Tunnel Techniques. ACL, ACLR, IKDC
17  2019 Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma. CSS, NARES, TSS-PROs
18  2019 Applying a value-based care framework to post-mastectomy reconstruction. ---
19  2019 Applying PRO Reference Values to Communicate Clinically Relevant Information at the Point-of-care. ---
20  2019 Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review. ---
21  2019 Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study. BBDC, PRO, PROMIS, RDCRN
22  2019 Assessing RA Disease Activity with PROMIS Measures using Digital Technology. CAT
23  2019 Assessment of Association Between Spino-Pelvic Parameters and Outcomes Following Gluteus Medius Repair. SVA
24  2019 Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. GI, OS-MMAS, PMO, QOL, TSQM
25  2019 Association between disease-specific anxiety at discharge and functional outcome in patients after total knee arthroplasty. KSS, TKA
26  2019 Burden of disease in patients with chronic hepatitisC in the Austrian REAL study. CHC, CP, DSV, EQ-5D-5L, SVR12
27  2019 Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis. axSpA, ECM, MMP, nr, PGDA
28  2019 Children with Enthesitis Have Worse Quality of Life, Function, and Pain, Irrespective of their Juvenile Arthritis Category. CHAQ, ERA, JAQQ, JIA, QoML, ReACCh-Out, VAS
29  2019 Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry. CHE
30  2019 Clinical factors associated with the overuse of asthma rescue medication. ACQ-5, HURM, LURM, TAI
31  2019 Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology. QOL
32  2019 Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome. AO, BCT, BT, EBRT, QOL
33  2019 Comparison of Outcomes Following Anterior vs Posterior Fusion Surgery for Patients With Degenerative Cervical Myelopathy: An Analysis From Quality Outcomes Database. LOS, mJOA, NDI, NRS, QOD, RTW
34  2019 Comparison of Postoperative Outcomes Between Primary MIS TLIF and MIS TLIF With Revision Decompression. LD
35  2019 Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. IBS, QOL
36  2019 Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. BDI-II, CHC, CLDQ-HCV, FACIT-F, FSS, SF-36, SVR
37  2019 Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study. FVC, ILD, IPF
38  2019 Development of Deployable Predictive Models for Minimal Clinically Important Difference Achievement Across the Commonly Used Health-Related Quality of Life Instruments in Adult Spinal Deformity Surgery. ASD, MAE, MCID, ODI, SRS-22
39  2019 Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer. GMH, GPH, PROMIS
40  2019 Do Female Athletes Return to Sports After Hip Preservation Surgery for Femoroacetabular Impingement Syndrome?: A Comparative Analysis. BMI, FAIS, HOS-ADL, HOS-SS, MCID, mHHS, PASS, VAS
41  2019 Do Femoral Head Osteochondral Lesions Predict a Poor Outcome in Hip Arthroscopy Patients? A Matched Control Study With Minimum 5-Year Follow-Up. FH, VAS
42  2019 Effect of Cigarette Smoking on Patient-Reported Outcomes in Hip Arthroscopic Surgery: A Matched-Pair Controlled Study With a Minimum 2-Year Follow-up. HOS-SSS, iHOT-12, mHHS, NAHS
43  2019 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond. ASQoL, BP, EQ-5D-3L, FACIT-Fatigue, PCS, PF, PGJS, PsA, PtGA, RP, SF, SF-36v2, TNFi-IR
44  2019 Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection and Psychiatric Disorders: An Integrated Analysis. AEs, DAA, G/P, HCV
45  2019 Evaluating the Concurrent Validity of PROMIS Physical Function in Anterior Cervical Discectomy and Fusion. ACDF, NDI, PF, PROMIS, SF-12, VAS
46  2019 Expert Consensus on Screening and Assessment of Cognition in Psychiatry. NPDs
47  2019 Exploratory analysis of treatment response trajectories in the Promoting Resilience in Stress Management (PRISM) Trial: models of psychosocial care. AYAs, MCIDs, PRISM, UC
48  2019 Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis. axSpA, BASFI, TNFi
49  2019 Five-Year Outcomes and Return to Sport of Runners Undergoing Hip Arthroscopy for Labral Tears With or Without Femoroacetabular Impingement. VAS
50  2019 Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. ADLs, CI, HE, HRQoL, ICT, IQR, MELD-Na, OR, PSQI
51  2019 Health Outcomes for Definite Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study. ---
52  2019 Health-related quality of life, psychosocial functioning, and unmet health needs in patients with sarcoma: A systematic review. HRQoL
53  2019 How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective. CGRP-mABs, EMA, FDA, QOL
54  2019 Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies. HRQoL, RCTs, SLE
55  2019 Impact of Contralateral Symmetry Procedures on Long-Term Patient-Reported Outcomes following Unilateral Prosthetic Breast Reconstruction. BR, CSP, HRQoL
56  2019 Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry. BSA, DLQI, EQ-VAS, IGA, WPAI
57  2019 Implementation of Value Based Breast Cancer Care. EHR, IPU, VBHC
58  2019 Implementation of Value-based Medicine (VBM) to Patients With Chronic Hepatitis C (HCV) Infection. HRQoL, VBM
59  2019 Improved patient-reported outcomes after autologous fat transplantation and corrective surgery after breast surgery. AFT, HRQoL, SSQ
60  2019 Improvement in Back and Leg Pain and Disability Following Adult Spinal Deformity Surgery: Study of 324 Patients With 2-year Follow-up and the Impact of Surgery on Patient-reported Outcomes. ASD, NRS, ODI, PT, SRS, SVA, TK
61  2019 Improving perioperative pain management: a preintervention and postintervention study in 7 developing countries. IASP, PIs, QI
62  2019 Increasing reoperation rates and inferior outcome with prolonged symptom duration in lumbar disc herniation surgery - a prospective cohort study. EQ-5D, LDH, ODI, VAS
63  2019 Interpreting and Acting on the PRO Scores From the Patient-reported Outcomes for Personalized Treatment and Care (PROMPT-Care) eHealth System. ---
64  2019 Is Traditional Chinese Medicine Use Associated with Worse Patient-Reported Outcomes Among Chinese-American Rheumatology Patients? PROMIS, TCM
65  2019 JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). AD
66  2019 Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials. ---
67  2019 Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America. CU, UCT
68  2019 Lessons learned while integrating patient-reported outcomes in a psychiatric hospital. ---
69  2019 Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. ACR, AEs, csDMARDs, DAS28, LTE, PY, RA, SAEs, TCZ
70  2019 Making a picture worth a thousand numbers: recommendations for graphically displaying patient-reported outcomes data. ---
71  2019 Meta-analysis of patient-reported outcomes after laparoscopic versus open inguinal hernia repair. RR
72  2019 Methods for evaluating quality of life and vision in patients undergoing lens refractive surgery. IOLs
73  2019 Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings. SCD
74  2019 Nonagenarians qualify for total knee arthroplasty: a report on 329 patients from the Swedish Knee Arthroplasty Register 2000-2016. OA, TKA
75  2019 Obesity is Independently Associated With Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus. BMI, CES-D, FMI, SF-36, SLAQ, SLE
76  2019 Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review. AQLQ, QOL
77  2019 Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology. FDA, NEI, PFDD
78  2019 Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. ABC, HR, PFS
79  2019 Patient reported outcome data as performance indicators in surgically treated lung cancer patients. DLCR, EORTC, GHS, RF
80  2019 Patient reported outcomes associated with surgical intervention for breast cancer. BCT, MR
81  2019 Patient reported outcomes for cancer patients receiving immunotherapy: opportunities for palliative care - A Systematic Review. HRQoL, ICIs
82  2019 Patient understanding, expectations, outcomes, and satisfaction regarding surgical management of shoulder instability. ---
83  2019 Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within arandomized controlled trial. GI, RCT, RT
84  2019 Patient-Reported and Functional Outcomes After Revision Amputation and Replantation of Digit Amputations: The FRANCHISE Multicenter International Retrospective Cohort Study. DASH, MHQ, PROMIS
85  2019 Patient-reported outcome measures among breast cancer survivors: A cross-sectional comparison between Malaysia and high-income countries. HICs, ICHOM
86  2019 Patient-Reported Outcome Measures for Adult Dental Patients: A Systematic Review. dPROMs
87  2019 Patient-reported outcomes (PRO) from a randomized, crossover trial comparing insulin degludec using FlexTouch with insulin glargine U100 using SoloSTAR pen-injectors in patients with type 2 diabetes. PRO, T2D
88  2019 Patient-reported outcomes (PROs) as a routine measure for cancer inpatients: the final missing piece of the puzzle? ---
89  2019 Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study. DLCR, EORTC
90  2019 Patient-reported outcomes 1 to 5 years after ACL reconstruction: effect of combined injury, and associations with MRI-defined osteoarthritis features. ACLR, BMLs, IKDC, KOOS, QOL
91  2019 Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. IGC
92  2019 Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study. GHS, HRQoL, mCRC
93  2019 Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States. PASI
94  2019 Patient-Reported Outcomes in Cardiothoracic Surgery. ---
95  2019 Patient-Reported Outcomes in Health Economic Decision-Making: A Changing Landscape in Oncology. ---
96  2019 Patient-reported outcomes in lasers and light therapy. PROMs
97  2019 Patient-reported outcomes in lung and esophageal cancer. HRQoL
98  2019 Patient-Reported Outcomes in Oncology, Beyond Randomized Controlled Trials. ---
99  2019 Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia. CP-CML, EQ-5D, FACT-Leu, HRQoL, mITT
100  2019 Patient-Reported Outcomes Measurement Information System Versus Legacy Instruments: Are They Ready for Prime Time? PROMIS